Depression and Hypothalamic-Pituitary-Adrenal Activation: A Quantitative Summary of Four Decades of Research

Objectives: To summarize quantitatively the literature comparing hypothalamic-pituitary-adrenal (HPA) axis function between depressed and nondepressed individuals and to describe the important sources of variability in this literature. These sources include methodological differences between studies, as well as demographic or clinical differences between depressed samples. Methods: The current study used meta-analytic techniques to compare 671 effect sizes (cortisol, adrenocorticotropic hormone, or corticotropin-releasing hormone) across 361 studies, including 18,454 individuals. Results: Although depressed individuals tended to display increased cortisol (d = 0.60; 95% confidence interval [CI], 0.54-0.66) and adrenocorticotropic hormone levels (d = 0.28; 95% CI, 0.16-0.41), they did not display elevations in corticotropin-releasing hormone (d = 0.02; 95% CI, −0.47-0.51). The magnitude of the cortisol effect was reduced by almost half (d = 0.33; 95% CI, 0.21-0.45) when analyses were limited to studies that met minimal methodological standards. Gender did not significantly modify any HPA outcome. Studies that included older hospitalized individuals reported significantly greater cortisol differences between depressed and nondepressed groups compared with studies with younger outpatient samples. Important cortisol differences also emerged for atypical, endogenous, melancholic, and psychotic forms of depression. Conclusions: The current study suggests that the degree of HPA hyperactivity can vary considerably across patient groups. Results are consistent with HPA hyperactivity as a link between depression and increased risk for conditions, such as diabetes, dementia, coronary heart disease, and osteoporosis. Such a link is strongest among older inpatients who display melancholic or psychotic features of depression. HPA = hypothalamic-pituitary-adrenal; ACTH = adrenocorticotropic hormone; CRH = corticotropin-releasing hormone; dex = dexamethasone; CI = confidence interval.

[1]  E. Walker,et al.  Diagnostic and Statistical Manual of Mental Disorders , 2013 .

[2]  K. Zakzanis,et al.  The impact of treatment on HPA axis activity in unipolar major depression. , 2010, Journal of psychiatric research.

[3]  J. Jokinen,et al.  HPA axis hyperactivity and cardiovascular mortality in mood disorder inpatients. , 2009, Journal of affective disorders.

[4]  R. Rupprecht,et al.  Hypothalamic–pituitary–adrenocortical system dysregulation and new treatment strategies in depression , 2009, Expert review of neurotherapeutics.

[5]  J. Suls,et al.  Associations of Depression With C-Reactive Protein, IL-1, and IL-6: A Meta-Analysis , 2009, Psychosomatic medicine.

[6]  Stafford L. Lightman,et al.  The HPA axis in major depression: classical theories and new developments , 2008, Trends in Neurosciences.

[7]  Xiao-Hua Zhou,et al.  Statistical Methods for Meta‐Analysis , 2008 .

[8]  T. Stiger,et al.  A 6-week randomized, placebo-controlled trial of CP-316,311 (a selective CRH1 antagonist) in the treatment of major depression. , 2008, The American journal of psychiatry.

[9]  Jaime L. Napier,et al.  Health psychology: developing biologically plausible models linking the social world and physical health. , 2009, Annual Review of Psychology.

[10]  C. Schüle Neuroendocrinological Mechanisms of Actions of Antidepressant Drugs , 2007, Journal of neuroendocrinology.

[11]  G. Miller,et al.  If it goes up, must it come down? Chronic stress and the hypothalamic-pituitary-adrenocortical axis in humans. , 2007, Psychological bulletin.

[12]  D. Mohr,et al.  Depression and cortisol responses to psychological stress: A meta-analysis , 2005, Psychoneuroendocrinology.

[13]  C. Lyketsos,et al.  Mood Disorders in the Medically Ill: Scientific Review and Recommendations , 2005, Biological Psychiatry.

[14]  N. Frasure-smith,et al.  Reflections on Depression as a Cardiac Risk Factor , 2005, Psychosomatic medicine.

[15]  S. Dickerson,et al.  Acute stressors and cortisol responses: a theoretical integration and synthesis of laboratory research. , 2004, Psychological bulletin.

[16]  B. McEwen,et al.  Association of depression with medical illness: does cortisol play a role? , 2004, Biological Psychiatry.

[17]  A. Schatzberg,et al.  Neuropsychological correlates of psychotic features in major depressive disorders: a review and meta-analysis. , 2004, Journal of psychiatric research.

[18]  J. Davidson,et al.  Depression with atypical features in the National Comorbidity Survey: classification, description, and consequences. , 2003, Archives of general psychiatry.

[19]  A. Schatzberg,et al.  Prevalence of depressive episodes with psychotic features in the general population. , 2002, The American journal of psychiatry.

[20]  G. Chrousos,et al.  Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH/NE states , 2002, Molecular Psychiatry.

[21]  G. Chrousos,et al.  Neuroendocrinology of stress. , 2001, Endocrinology and metabolism clinics of North America.

[22]  Yuk Fai Cheong,et al.  HLM 6: Hierarchical Linear and Nonlinear Modeling , 2000 .

[23]  P. Björntorp,et al.  The hypothalamic–pituitary–adrenal axis activity as a predictor of cardiovascular disease, type 2 diabetes and stroke , 2000, Journal of internal medicine.

[24]  G. Chrousos,et al.  Clinical review 104: Adrenocorticotropin (ACTH)- and non-ACTH-mediated regulation of the adrenal cortex: neural and immune inputs. , 1999, The Journal of clinical endocrinology and metabolism.

[25]  A. Convit,et al.  Cortisol levels during human aging predict hippocampal atrophy and memory deficits , 1998, Nature Neuroscience.

[26]  Jack L. Vevea,et al.  Fixed- and random-effects models in meta-analysis. , 1998 .

[27]  P. Shapiro,et al.  Depression and the course of coronary artery disease. , 1998, The American journal of psychiatry.

[28]  J. Davis,et al.  DST studies in psychotic depression: a meta-analysis. , 1997, The American journal of psychiatry.

[29]  S. Raudenbush,et al.  A multivariate mixed linear model for meta-analysis. , 1996 .

[30]  A. Rush,et al.  Melancholic symptom features and DSM-IV. , 1994, The American journal of psychiatry.

[31]  S. Cohen,et al.  Depression and immunity: a meta-analytic review. , 1993, Psychological bulletin.

[32]  C. Nemeroff,et al.  Physiology and pharmacology of corticotropin-releasing factor. , 1991, Pharmacological reviews.

[33]  N. Matussek Biological aspects of depression. , 1986, Psychopathology.

[34]  Shelley E. Taylor Hospital Patient Behavior: Reactance, Helplessness, or Control? , 1979 .